楊順發張子晏Tz-Yan Chang醫學研究所2026-10-299999-12-312019https://handle.ncl.edu.tw/11296/a3w942https://scholars.csmu.edu.tw/handle/123456789/36473肺癌(lung cancer)是全球發生率最高的癌症,目前在肺癌EGFR突變的研究上發現,EGFR的突變偏好於病理為腺癌的分型。在肺癌形成過程中,與腫瘤的微環境缺氧(hypoxia)有很大的相關性,但是一些hypoxia相關因子及碳酸酐異構酶 (carbonic anhydrase; CA)的基因多型性與肺癌的相關性卻仍不清楚。本研究收集194位肺癌病人的血液,利用real time PCR genotype的分析方式探討缺氧相關基因如HIF-1α及CA9之基因多型性與肺癌患者其EGFR突變的相關性。我們在本研究中觀察HIF-1α其exon 12中P582S (rs11549465)及A588T (rs11549467)的變異以及CA9其rs2071676、rs3829078、rs1048638的變異。結果發現,在缺氧相關基因其CA9基因多型性rs1048638在不抽菸的病人中與EGFR突變有關聯,這表示CA9基因的多型性可能與非吸菸族群中肺腺癌的EGFR突變有關。Lung cancer is the first leading cause of death from cancer. Several studies have indicated that the mutations of EGFR are common in lung adenocarcinomas. The capability of tumor cells to sense hypoxia for enhancing cells proliferation, invasion, and metastasis is one of the critical components for cancer development. Hypoxia inducible factor-1-alpha (HIF-1α) and carbonic anhydrase 9 (CA9) have been investigated as an endogenous marker for tumor hypoxia. Our hypothesis suggests that the gene variations in HIF-1α and CA9 are associated with EGFR mutations of lung cancer. Five SNPs, including HIF-1α rs11549465, rs11549467, CA9 rs2071676, rs3829078 and rs1048638 were observed from 194 patients with lung cancer. The results indicated that a CA9 SNP, rs1048638, was significant associated with EGFR mutations in never-smoker lung cancer patients.HIF1αCA9表皮生長因子肺腺癌基因多型性Epidermal growth factor receptorEGFRlung adenocarcinomasingle nucleotide polymorphismsSNPs缺氧相關基因其基因多型性與肺癌患者EGFR突變的相關性探討thesis